News Conference News AHA 2025 LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF Caitlin E. Cox November 09, 2025
News Conference News AHA 2025 DECAF: Daily Coffee, Not Abstinence, Beneficial for AF Patients Michael O'Riordan November 09, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Conference News AHA 2025 Stopping DOACs After Successful AF Ablation Feasible in Low-risk Patients: OCEAN Michael O'Riordan November 08, 2025
News Conference News AHA 2025 One Month of Dual Antithrombotic Therapy May Be Enough After PCI in AF Patients Todd Neale November 08, 2025
News Daily News Heavy Alcohol Use Tied to More-Severe Intracerebral Hemorrhages Todd Neale November 06, 2025
News Opinion Editor's Corner AHA 2025 What’s Going to Be Hot at AHA 2025? Michael O'Riordan November 05, 2025
News Conference News TCT 2025 What Makes MedTech Great—or Not—and Envisioning Its Future Caitlin E. Cox November 04, 2025
News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
Presentation TCT 2025 TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction Presenter: Xiaochun Zhang October 28, 2025
Presentation TCT 2025 TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation Presenter: Kuseme Udoh October 28, 2025
Presentation TCT 2025 TCT 744: Risk of Recurrent Gastrointestinal Bleeding in Patients with Atrial Fibrillation Treated With or Without Left Atrial Appendage Occlusion: A Propensity-Matched Analysis Presenter: Adham Ramadan October 28, 2025
Presentation TCT 2025 TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting Presenter: Muhammad Zahid October 28, 2025
Presentation TCT 2025 TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis Presenter: Thomas E. Waggoner October 28, 2025
Presentation TCT 2025 TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention Presenter: Khaled Elnaggar October 28, 2025
Presentation TCT 2025 TCT 738: Percutaneous LAA closure in patients with non-valvular atrial fibrillation and cancer Presenter: Carlos Eduardo Vergara Uzcategui October 28, 2025
Presentation TCT 2025 TCT 742: Risks of Major Bleeding and Hospitalization for Falls After Left Atrial Appendage Occlusion in Patients with Atrial Fibrillation and History of Falls: A Propensity-Matched Analysis Presenter: Mohamed Doma October 28, 2025
Presentation TCT 2025 TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation Presenter: Devi G. Nair October 28, 2025
Presentation TCT 2025 TCT 733: CHA2DS2-VASc Score As a Predictor for Outcomes Following Left Atrial Appendage Closure Devices in Non-valvular Atrial Fibrillation; A Retrospective Analysis Presenter: Joud Fahed October 28, 2025
News Conference News TCT 2025 ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR Todd Neale October 27, 2025